Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 15;208(4):344-346.
doi: 10.1164/rccm.202307-1164ED.

A New Treatment for Chronic Obstructive Pulmonary Disease: Ensifentrine Moves Closer

Dave Singh  1
Affiliations
Editorial

A New Treatment for Chronic Obstructive Pulmonary Disease: Ensifentrine Moves Closer

Dave Singh. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Lipson DA, Barnhart F, Brealey N, Brooks J, Criner GJ, Day NC, et al. IMPACT Investigators Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med . 2018;378:1671–1680. - PubMed
    1. Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, et al. ETHOS Investigators Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N Engl J Med . 2020;383:35–48. - PubMed
    1. Singh D, Agusti A, Martinez FJ, Papi A, Pavord ID, Wedzicha JA, et al. Blood eosinophils and chronic obstructive pulmonary disease: a Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review. Am J Respir Crit Care Med . 2022;206:17–24. - PubMed
    1. Singh D, Lea S, Mathioudakis AG. Inhaled phosphodiesterase inhibitors for the treatment of chronic obstructive pulmonary disease. Drugs . 2021;81:1821–1830. - PubMed
    1. Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ, M2-124 and M2-125 study groups Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet . 2009;374:685–694. - PubMed

MeSH terms